Victor Sandor - Nov 3, 2022 Form 3 Insider Report for Kymera Therapeutics, Inc. (KYMR)

Role
Director
Signature
/s/ Bruce Jacobs, as Attorney-in-Fact
Stock symbol
KYMR
Transactions as of
Nov 3, 2022
Transactions value $
$0
Form type
3
Date filed
11/3/2022, 07:19 PM
Previous filing
Jun 22, 2022
Next filing
Jun 12, 2023

No securities are beneficially owned.

Remarks:

Exhibit 24: Power of Attorney